Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      MyOme Demonstrates Clinical Validity of Integrated Polygenic and Clinical Risk Prediction for Coronary Artery Disease

      MyOme, a clinical whole genome sequencing and analysis platform company (PRNewsfoto/MyOme, Inc)

      News provided by

      MyOme, Inc

      Mar 20, 2026, 07:00 ET

      Share this article

      Share this article


      Findings come as ACC/AHA guidelines recognize polygenic risk as an ASCVD risk enhancer

      MENLO PARK, Calif., March 20, 2026 /PRNewswire/ -- MyOme, a leader in clinical whole-genome analysis and integrated risk modeling, today announced research showing that integrating polygenic scores with clinical risk factors produces more precise and stable coronary artery disease (CAD) predictions than either approach alone. The announcement comes ahead of the ACC Annual Scientific Session, as updated ACC/AHA guidelines increasingly recognize the role of genomics in standard cardiovascular care.

      New ACC/AHA Guidelines Highlight Genetic Risk Enhancers

      Newly released 2026 ACC/AHA dyslipidemia guidelines recognize high polygenic risk as an atherosclerotic cardiovascular disease (ASCVD) risk enhancer, alongside established factors such as family history of premature ASCVD, elevated lipoprotein(a), inflammatory markers, and metabolic risk factors.[1] 

      This update reflects a broader shift in cardiovascular prevention—moving beyond traditional risk calculators toward more comprehensive risk assessment that integrates genetic and clinical factors, an approach central to MyOme's integrated risk modeling platform.

      Polygenic risk scores aggregate the effects of thousands to millions of genetic variants across the genome to quantify inherited susceptibility to disease. Landmark studies have demonstrated that individuals with high polygenic risk may have threefold or greater risk of developing coronary artery disease, comparable to the risk conferred by certain monogenic mutations.[2,3]

      Risk enhancers refine cardiovascular risk estimates when traditional calculators leave uncertainty. In patients with borderline or intermediate risk—such as those assessed using traditional tools like the PREVENT-ASCVD equation—risk enhancers can influence decisions about earlier lipid-lowering therapy, additional screening, or lifestyle interventions.[1]

      Together, these changes highlight the growing need for approaches that can reliably integrate genetic and clinical risk factors in individual patients.

      "The inclusion of polygenic risk in the ACC/AHA guidelines reflects a steady march toward clinical adoption of genomics-enabled tools that identify those who are 'flying under the radar' and could benefit from earlier intervention," said Dr. Akash Kumar, co-founder of MyOme. "This is at the core of what we have been building at MyOme."

      Study Evaluates Stability of Integrated Genetic and Clinical Risk Prediction

      MyOme is addressing a key challenge in the clinical adoption of polygenic risk scores (PRS): variability in individual risk classification across models.

      The study, authored by investigators at MyOme and published in the American Journal of Preventive Cardiology, evaluates the consistency of integrated genetic and clinical risk models—an important consideration as genomic risk tools move closer to routine clinical use.[4] These findings align with the 2026 ACC/AHA guidelines, which position polygenic risk as an ASCVD risk enhancer alongside established clinical factors, and support a broader shift toward integrating genomic and clinical data in cardiovascular risk assessment.

      "Polygenic risk captures inherited susceptibility to coronary artery disease that is not reflected in traditional clinical risk factors alone," said Dr. Akl Fahed, M.D., M.P.H., cardiologist and physician-scientist at Massachusetts General Hospital. "This study shows that integrating genetic and clinical risk factors can yield more consistent and reproducible risk estimates, supporting the potential role of combined models in preventive cardiology." Dr. Fahed is an author of the study and a paid consultant to MyOme.

      MyOme has taken this integrated approach by design—combining polygenic risk with established clinical predictors to provide a more comprehensive view of cardiovascular risk. The study provides further support for the consistency and reliability of this approach at the individual patient level, an important requirement for clinical implementation.

      The research can be viewed here: https://myome.com/posters/AJPC%202026%20Stability%20of%20integrated%20polygenic%20and%20clinical%20coronary%20artery%20disease%20risk%20prediction.pdf

      ACC 2026

      MyOme will be attending the American College of Cardiology (ACC) Annual Scientific Session. Attendees can meet the MyOme team at the Future Hub, Booth 14, to discuss advances in genomic risk prediction and preventive cardiology.

      About MyOme

      MyOme is a clinical whole genome analysis company helping families understand their risk for diseases. As a leader in polygenic and AI-based integrative risk modeling, MyOme's platform combines genome sequencing with AI-driven analytics to integrate polygenic risk scores with established clinical predictors, enabling a more comprehensive approach to cardiovascular and disease risk assessment. MyOme leverages the power of the whole genome and clinical data for a lifetime of meaningful and actionable insights. These capabilities can dramatically reduce healthcare costs and improve outcomes by identifying disease risk earlier and enabling preventive interventions. Certified under the Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP), MyOme is based in Menlo Park, California.

      References

      1. Blumenthal RS, Morris PB, et al. 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia. Journal of the American College of Cardiology / Circulation.
      2. Khera AV et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nature Genetics. 2018.
        https://www.nature.com/articles/s41588-018-0183-z
      3. Inouye M et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults. Journal of the American College of Cardiology. 2018.
        https://www.jacc.org/doi/10.1016/j.jacc.2018.07.079
      4. Ratman D, Maier R, Kumar A, Rabinowitz M, Im K, Fahed AC. Stability of integrated polygenic and clinical coronary artery disease risk prediction. American Journal of Preventive Cardiology. 2026. https://www.sciencedirect.com/science/article/pii/S2666667726001029

      SOURCE MyOme, Inc

      Modal title

      Also from this source

      MyOme Launches CASRcade, a No Charge Family Cascade Genetic Testing Program for Families Affected by ADH1

      MyOme Launches CASRcade, a No Charge Family Cascade Genetic Testing Program for Families Affected by ADH1

      MyOme today announced CASRcade, a cascade genetic testing program sponsored by BridgeBio for families affected by Autosomal Dominant Hypocalcemia...

      MyOme and Oracle Collaborate to Advance Genomic Risk Prediction at Global Scale

      MyOme and Oracle Collaborate to Advance Genomic Risk Prediction at Global Scale

      MyOme, Inc., a leader in clinical whole-genome analysis and polygenic risk modeling, today announced that its predictive genomic insights platform...

      More Releases From This Source

      Explore

      Artificial Intelligence

      Artificial Intelligence

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Computer & Electronics

      Computer & Electronics

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.